23.04.2013 Views

Management of Commercially Generated Radioactive Waste - U.S. ...

Management of Commercially Generated Radioactive Waste - U.S. ...

Management of Commercially Generated Radioactive Waste - U.S. ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

E.2 GENETIC EFFECTS<br />

E.!<br />

It is known that genetic effects result from alterations within genes, called muta-<br />

tions, or from rearrangements <strong>of</strong> genes within chromosomes. There is no radiation-dose<br />

threshold for the production <strong>of</strong> mutations, but repair <strong>of</strong> damage to genetic material can<br />

occur during exposure at low dose rates. This information is reviewed and discussed at<br />

length in the 1977 UNSCEAR Report.<br />

The conventional approach to this problem has been to estimate a "mutation doubling<br />

dose," i.e., the radiation dose required to double the existing mutation rate. The BEIR<br />

Report concludes that this doubling dose for humans lies in the range <strong>of</strong> 20 to 200 rem. The<br />

UNSCEAR Report considers additional experimental data and opts for a single value <strong>of</strong><br />

100 rem. Given a number for the doubling dose, if one can assume that radiation-induced<br />

mutations have the same effect on health as normally occurring mutations and if one knows<br />

the burden <strong>of</strong> human ill health attributable to such normally occurring mutations, one can<br />

directly estimate the genetic effect <strong>of</strong> any given radiation dose. Unfortunately, it is not<br />

clear that radiation-induced mutations are equivalent in effect to normally occurring muta-<br />

tions. Nor is there any confidently accepted quantification <strong>of</strong> the human ill health attrib-<br />

utable to these normally occurring mutations.<br />

Four kinds <strong>of</strong> specifically recognized genetically associated diseases are usually<br />

distinguished.<br />

1. Autosomal dominant disorders are those caused by the presence <strong>of</strong> a single gene.<br />

The most common examples are: chondrodystrophy (abnormal cartilage development),<br />

osteogenesis imperfecta (abnormally brittle bones), neur<strong>of</strong>ibromatosis (disease<br />

characterized by multiple s<strong>of</strong>t tumors), eye anomalies including congenital<br />

cataract, and polydactylism (more than 10 fingers or toes) (Trimble and Doughty<br />

1974). It is generally agreed that these disorders will double in frequency if<br />

the mutation rate is doubled (NAS-NRC 1972 and UNSCEAR 1977). There is some dis-<br />

agreement on their normal frequency <strong>of</strong> occurrence: the earlier data (Stevenson<br />

1959) employed in the BEIR Report indicate a 1% normal incidence, while a more<br />

recent study <strong>of</strong> and Trimble and Doughty 1974), indicates an incidence <strong>of</strong><br />

something less than 0.1%. These new data have not been fully accepted, however,<br />

and the 1977 UNSCEAR Report continues to employ the 1% normal incidence figures.<br />

2. Multifactorial (irregularly inherited) disorders have a more complex and ill-<br />

defined pattern <strong>of</strong> inheritance. These diseases include a wide variety <strong>of</strong> congenital<br />

malformations and constitutional and degenerative diseases. Their normal<br />

incidence in the population was estimated in the BEIR Report to be about 4% (NAS-<br />

NRC 1972); however, the newer data <strong>of</strong> Doughty and Trimble suggest an incidence as<br />

high as 9-10%'(UNSCEAR 1977). The BEIR Report states that, "The extent to which<br />

the incidence <strong>of</strong> these diseases depends on mutation is not known" but assumes a<br />

"mutational component" <strong>of</strong> 5 to 50% (p. 56). The 1977 UNSCEAR Report employs a<br />

single figure <strong>of</strong> 5% and considers 10% to be an upper limit (p. 429). Newcombe has<br />

argued that "the bulk <strong>of</strong> the most directly pertinent experimental studies thus

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!